Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
| Aktionär | Typ | Gehalten (Tatsächlich) | % Ausstehender Aktien | Marktwert | Positionsdatum |
|---|---|---|---|---|---|
| JPMorgan Chase & Co. | Institution | 21.028.373 | 10,12% | US$ 73,60M | 2026-05-18 |
| Invus Public Equities, L.P. | Institution | 15.945.067 | 7,68% | US$ 55,81M | 2025-11-13 |
| Artal Group S.A. | Institution | 15.945.067 | 7,68% | US$ 55,81M | 2025-11-13 |
| Andera Partners | Institution | 14.114.476 | 6,80% | US$ 49,40M | 2026-03-31 |
| Biodiscovery 6 FPCI | Institution | 14.114.476 | 6,80% | US$ 49,40M | 2025-12-31 |
| Samsara BioCapital LLC | Institution | 13.540.194 | 6,52% | US$ 47,39M | 2026-03-31 |
| Sofinnova Crossover I | Institution | 12.332.804 | 5,94% | US$ 43,16M | 2025-12-31 |
| Eventide Asset Management, LLC | Institution | 9.368.517 | 4,51% | US$ 32,79M | 2026-03-31 |
| Eventide Healthcare Innovation Fund I LP | Institution | 9.368.517 | 4,51% | US$ 32,79M | 2025-12-31 |
| BVF Partners L.P. | Institution | 8.545.499 | 4,11% | US$ 29,91M | 2026-03-31 |
| Sofinnova Partners SAS | Institution | 8.433.227 | 4,06% | US$ 29,52M | 2026-06-02 |
| Samsara Biocapital, L.P. | Institution | 8.345.389 | 4,02% | US$ 29,21M | 2025-11-17 |
| Deep Track Capital, LP | Institution | 7.800.465 | 3,76% | US$ 27,30M | 2026-03-31 |
| Deep Track Biotechnology Master Fund, Ltd | Institution | 7.800.465 | 3,76% | US$ 27,30M | 2026-03-31 |
| Perceptive Advisors LLC | Institution | 6.945.995 | 3,34% | US$ 24,31M | 2025-09-30 |
| Perceptive Life Sciences Master Fund, Ltd. | Institution | 6.945.995 | 3,34% | US$ 24,31M | 2025-09-30 |
| Sofinnova Crossover Ii S.L.P. | Institution | 6.753.246 | 3,25% | US$ 23,64M | 2025-12-31 |
| New Enterprise Associates, Inc. | Institution | 6.684.064 | 3,22% | US$ 23,39M | 2026-03-31 |
| New Enterprise Associates 17, L.P. | Institution | 6.684.064 | 3,22% | US$ 23,39M | 2026-03-30 |
| Mr. Frederic Cren | Insider | 5.878.991 | 2,83% | US$ 20,58M | 2026-03-04 |
| Samsara Opportunity Fund, L.P. | Institution | 5.194.805 | 2,50% | US$ 18,18M | 2025-11-17 |
| Qatar Holding LLC | Institution | 5.157.233 | 2,48% | US$ 18,05M | 2025-07-22 |
| Caligan Partners, LP | Institution | 4.974.906 | 2,40% | US$ 17,41M | 2026-03-31 |
| Polar Capital Holdings Plc | Institution | 4.632.138 | 2,23% | US$ 16,21M | 2026-03-31 |
| Biotechnology Value Fund L.P. | Institution | 4.630.461 | 2,23% | US$ 16,21M | 2025-11-17 |
| Paradigm Biocapital Advisors LP | Institution | 4.000.000 | 1,93% | US$ 14,00M | 2026-03-31 |
| Biomedical Value Fund | Institution | 3.658.944 | 1,76% | US$ 12,81M | 2025-09-30 |
| Great Point Partners, LLC | Institution | 3.449.937 | 1,66% | US$ 12,07M | 2025-12-31 |
| Dr. Pierre Broqua | Insider | 3.428.070 | 1,65% | US$ 12,00M | 2026-03-04 |
| Biotechnology Value Fund II, L.P. | Institution | 3.321.861 | 1,60% | US$ 11,63M | 2025-11-17 |
| Millennium Management LLC | Institution | 2.987.613 | 1,44% | US$ 10,46M | 2026-03-31 |
| Trails Edge Capital Partners, LP | Institution | 2.657.997 | 1,28% | US$ 9,30M | 2026-03-31 |
| Franklin Resources, Inc. | Institution | 2.461.565 | 1,19% | US$ 8,62M | 2026-03-31 |
| Symbiosis Capital Partners, LLC | Institution | 2.354.000 | 1,13% | US$ 8,24M | 2026-03-31 |
| UBS Asset Management AG | Institution | 2.318.693 | 1,12% | US$ 8,12M | 2026-03-31 |
| Ally Bridge Group | Institution | 2.245.300 | 1,08% | US$ 7,86M | 2026-03-31 |
| ADAR1 Capital Management, LLC | Institution | 2.174.398 | 1,05% | US$ 7,61M | 2026-03-31 |
| The Goldman Sachs Group, Inc. | Institution | 1.932.160 | 0,93% | US$ 6,76M | 2026-03-31 |
| NEA 18 Venture Growth Equity, L.P. | Institution | 1.666.666 | 0,80% | US$ 5,83M | 2026-03-30 |
| Biomedical Offshore Value Fund, LTD. | Institution | 1.643.874 | 0,79% | US$ 5,75M | 2025-09-30 |
| Boothbay Fund Management, LLC | Institution | 1.470.407 | 0,71% | US$ 5,15M | 2026-03-31 |
| Ikarian Capital, LLC | Institution | 1.429.101 | 0,69% | US$ 5,00M | 2026-03-31 |
| Inventiva S.A. Esop | Institution | 1.338.127 | 0,64% | US$ 4,68M | 2024-10-15 |
| Nextbio Capital Management Lp | Institution | 1.333.484 | 0,64% | US$ 4,67M | 2026-03-31 |
| RTW Investments, LP | Institution | 1.298.702 | 0,63% | US$ 4,55M | 2026-03-31 |
| Artisan Partners Limited Partnership | Institution | 960.865 | 0,46% | US$ 3,36M | 2026-03-31 |
| Point72 Asset Management, L.P. | Institution | 956.221 | 0,46% | US$ 3,35M | 2026-03-31 |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
